SEC Form 4 Reporting Owner · CIK 0001257809
Frank Mccormick
Director at BridgeBio Pharma Inc · Director at BridgeBio Oncology Therapeutics Inc
Bought (12 mo)
—
Sold (12 mo)
−$13.3M
Form 4 Filings
13
Companies
2
Filing Activity
2026-06-24
first filed 2023-02-23
Trading record
Open-market buys
—
0 filings
Open-market sales
−$25.9M
5 filings
Sales under a 10b5-1 plan
80%
4 of 5 sale filings
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| BBIOBridgeBio Pharma Insider trading | Director | 11 | — | 474,000 | −474,000 | 767,244 2026-06-24 |
| BBOTBridgeBio Insider trading | Director | 2 | — | — | — | — |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.